Liver Cancer Therapeutics Market, Global Outlook and Forecast 2022-2028

April 2022 | 67 pages | ID: L100C7C9FB52EN
Market Monitor Global

Abstracts

Liver cancer, also known as hepatic cancer and primary hepatic cancer, is cancer that starts in the liver. Cancer which has spread from elsewhere to the liver, known as liver metastasis, is more common than that which starts in the liver. Symptoms of liver cancer may include a lump or pain in the right side below the rib cage, swelling of the abdomen, yellowish skin, easy bruising, weight loss, and weakness. The treatment of liver cancer patients is mainly determined by the organ involved, the tumor spread, the patient's general condition and age.

This report contains market size and forecasts of Liver Cancer Therapeutics in Global, including the following market information:

Global Liver Cancer Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Liver Cancer Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Targeted Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Liver Cancer Therapeutics include ArQule, Bayer, Bristol-Myers Squibb, Celsion, Eisai, Exelixis, Roche, Merck and Pfizer and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liver Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Liver Cancer Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Liver Cancer Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Targeted Therapy
• Radiation Therapy
• Immunotherapy
• Chemotherapy
• Other

Global Liver Cancer Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Liver Cancer Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hepatocellular Carcinoma
• Cholangio Carcinoma
• Hepatoblastoma
• Other

Global Liver Cancer Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Liver Cancer Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Liver Cancer Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Liver Cancer Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• ArQule
• Bayer
• Bristol-Myers Squibb
• Celsion
• Eisai
• Exelixis
• Roche
• Merck
• Pfizer
• IntegraGen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Liver Cancer Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Liver Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LIVER CANCER THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Liver Cancer Therapeutics Market Size: 2021 VS 2028
2.2 Global Liver Cancer Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Liver Cancer Therapeutics Players in Global Market
3.2 Top Global Liver Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Liver Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Liver Cancer Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Liver Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Liver Cancer Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Liver Cancer Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Liver Cancer Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Liver Cancer Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Targeted Therapy
  4.1.3 Radiation Therapy
  4.1.4 Immunotherapy
  4.1.5 Chemotherapy
  4.1.6 Other
4.2 By Type - Global Liver Cancer Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Liver Cancer Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Liver Cancer Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Liver Cancer Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Liver Cancer Therapeutics Market Size, 2021 & 2028
  5.1.2 Hepatocellular Carcinoma
  5.1.3 Cholangio Carcinoma
  5.1.4 Hepatoblastoma
  5.1.5 Other
5.2 By Application - Global Liver Cancer Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Liver Cancer Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Liver Cancer Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Liver Cancer Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Liver Cancer Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Liver Cancer Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Liver Cancer Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Liver Cancer Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Liver Cancer Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Liver Cancer Therapeutics Revenue, 2017-2028
  6.3.2 US Liver Cancer Therapeutics Market Size, 2017-2028
  6.3.3 Canada Liver Cancer Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Liver Cancer Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Liver Cancer Therapeutics Revenue, 2017-2028
  6.4.2 Germany Liver Cancer Therapeutics Market Size, 2017-2028
  6.4.3 France Liver Cancer Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Liver Cancer Therapeutics Market Size, 2017-2028
  6.4.5 Italy Liver Cancer Therapeutics Market Size, 2017-2028
  6.4.6 Russia Liver Cancer Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Liver Cancer Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Liver Cancer Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Liver Cancer Therapeutics Revenue, 2017-2028
  6.5.2 China Liver Cancer Therapeutics Market Size, 2017-2028
  6.5.3 Japan Liver Cancer Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Liver Cancer Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Liver Cancer Therapeutics Market Size, 2017-2028
  6.5.6 India Liver Cancer Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Liver Cancer Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Liver Cancer Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Liver Cancer Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Liver Cancer Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Liver Cancer Therapeutics Market Size, 2017-2028
  6.7.3 Israel Liver Cancer Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Liver Cancer Therapeutics Market Size, 2017-2028
  6.7.5 UAE Liver Cancer Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 ArQule
  7.1.1 ArQule Corporate Summary
  7.1.2 ArQule Business Overview
  7.1.3 ArQule Liver Cancer Therapeutics Major Product Offerings
  7.1.4 ArQule Liver Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 ArQule Key News
7.2 Bayer
  7.2.1 Bayer Corporate Summary
  7.2.2 Bayer Business Overview
  7.2.3 Bayer Liver Cancer Therapeutics Major Product Offerings
  7.2.4 Bayer Liver Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Bayer Key News
7.3 Bristol-Myers Squibb
  7.3.1 Bristol-Myers Squibb Corporate Summary
  7.3.2 Bristol-Myers Squibb Business Overview
  7.3.3 Bristol-Myers Squibb Liver Cancer Therapeutics Major Product Offerings
  7.3.4 Bristol-Myers Squibb Liver Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Bristol-Myers Squibb Key News
7.4 Celsion
  7.4.1 Celsion Corporate Summary
  7.4.2 Celsion Business Overview
  7.4.3 Celsion Liver Cancer Therapeutics Major Product Offerings
  7.4.4 Celsion Liver Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Celsion Key News
7.5 Eisai
  7.5.1 Eisai Corporate Summary
  7.5.2 Eisai Business Overview
  7.5.3 Eisai Liver Cancer Therapeutics Major Product Offerings
  7.5.4 Eisai Liver Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Eisai Key News
7.6 Exelixis
  7.6.1 Exelixis Corporate Summary
  7.6.2 Exelixis Business Overview
  7.6.3 Exelixis Liver Cancer Therapeutics Major Product Offerings
  7.6.4 Exelixis Liver Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Exelixis Key News
7.7 Roche
  7.7.1 Roche Corporate Summary
  7.7.2 Roche Business Overview
  7.7.3 Roche Liver Cancer Therapeutics Major Product Offerings
  7.7.4 Roche Liver Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Roche Key News
7.8 Merck
  7.8.1 Merck Corporate Summary
  7.8.2 Merck Business Overview
  7.8.3 Merck Liver Cancer Therapeutics Major Product Offerings
  7.8.4 Merck Liver Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Merck Key News
7.9 Pfizer
  7.9.1 Pfizer Corporate Summary
  7.9.2 Pfizer Business Overview
  7.9.3 Pfizer Liver Cancer Therapeutics Major Product Offerings
  7.9.4 Pfizer Liver Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Pfizer Key News
7.10 IntegraGen
  7.10.1 IntegraGen Corporate Summary
  7.10.2 IntegraGen Business Overview
  7.10.3 IntegraGen Liver Cancer Therapeutics Major Product Offerings
  7.10.4 IntegraGen Liver Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 IntegraGen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Liver Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Liver Cancer Therapeutics Market Drivers in Global Market
Table 3. Liver Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Liver Cancer Therapeutics in Global Market
Table 5. Top Liver Cancer Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Liver Cancer Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Liver Cancer Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Liver Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Liver Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liver Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Liver Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Liver Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Liver Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Liver Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Liver Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Liver Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Liver Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Liver Cancer Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Liver Cancer Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Liver Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Liver Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Liver Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Liver Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Liver Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. ArQule Corporate Summary
Table 31. ArQule Liver Cancer Therapeutics Product Offerings
Table 32. ArQule Liver Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Bayer Corporate Summary
Table 34. Bayer Liver Cancer Therapeutics Product Offerings
Table 35. Bayer Liver Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Corporate Summary
Table 37. Bristol-Myers Squibb Liver Cancer Therapeutics Product Offerings
Table 38. Bristol-Myers Squibb Liver Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Celsion Corporate Summary
Table 40. Celsion Liver Cancer Therapeutics Product Offerings
Table 41. Celsion Liver Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Eisai Corporate Summary
Table 43. Eisai Liver Cancer Therapeutics Product Offerings
Table 44. Eisai Liver Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Exelixis Corporate Summary
Table 46. Exelixis Liver Cancer Therapeutics Product Offerings
Table 47. Exelixis Liver Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Roche Corporate Summary
Table 49. Roche Liver Cancer Therapeutics Product Offerings
Table 50. Roche Liver Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Merck Corporate Summary
Table 52. Merck Liver Cancer Therapeutics Product Offerings
Table 53. Merck Liver Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Liver Cancer Therapeutics Product Offerings
Table 56. Pfizer Liver Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. IntegraGen Corporate Summary
Table 58. IntegraGen Liver Cancer Therapeutics Product Offerings
Table 59. IntegraGen Liver Cancer Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Liver Cancer Therapeutics Segment by Type in 2021
Figure 2. Liver Cancer Therapeutics Segment by Application in 2021
Figure 3. Global Liver Cancer Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Liver Cancer Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Liver Cancer Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Liver Cancer Therapeutics Revenue in 2021
Figure 8. By Type - Global Liver Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Liver Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Liver Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Liver Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Liver Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Liver Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Liver Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Liver Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Liver Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. ArQule Liver Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer Liver Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Liver Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Celsion Liver Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Eisai Liver Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Exelixis Liver Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Roche Liver Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merck Liver Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Liver Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. IntegraGen Liver Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)